Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Medicare Final Rule for 2010
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Using Embryonic Stem Cells to Test Breast Cancer Genes
Sara Hartley, MDLinx Oncology
Technology Advances: Nanotech PSA Levels Unmask Lingering Prostate Cancer
Dorothy J. Schirf, MD, MDLinx Oncology
  See all

Articles: Myeloproliferative Dz



Latest (1) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes
Seminars in Hematology, 07/27/09
Sponsor
Clinical and immunological evaluation of zoledronate-activated Vgamma9gamma delta T-cell-based immunotherapy for patients with multiple myeloma
Experimental Hematology, 07/27/09
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: Identification of potential therapeutic targets
Experimental Hematology, 07/27/09
Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4+ subset and oligoclonal in the CD8+ subset
Experimental Hematology, 07/27/09
Infections in Patients With Multiple Myeloma
Seminars in Hematology, 07/27/09
Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma
British Journal of Haematology, 07/21/09
Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease - implications for clinical trial design and enrollment
Blood, 07/21/09
Single-agent bortezomib in previously untreated multiple myeloma: Efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy
Journal of Clinical Oncology, 07/20/09
Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: A southwest oncology group trial (S0204)
Journal of Clinical Oncology, 07/20/09
The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: A systematic review
Cancer Treatment Reviews, 07/20/09
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group
Annals of Oncology, 07/17/09
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes
Annals of Oncology, 07/17/09
5q– myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics
Oncogene, 07/16/09
Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms
Cancer Epidemiology, Biomarkers & Prevention, 07/15/09
Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: A retrospective study of 322 bone marrows
Leukemia Research, 07/13/09
p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma
Leukemia Research, 07/13/09
The ambiguous role of interferon regulatory factor-1 (IRF-1) immunoexpression in myelodysplastic syndrome
Leukemia Research, 07/13/09
Azacitidine for the treatment of myelodysplastic syndrome
Expert Review of Anticancer Therapy, 07/13/09
Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myeloma
Expert Review of Anticancer Therapy, 07/13/09
NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes
British Journal of Haematology, 07/09/09
Exclusive Author Commentary


Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
187 Available Pages
First    Prev    7      8      9      10      11      12      13      14      15      16      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.